Author | Steven A. Kaplan, MD

June 11, 2020

"In the current environment of coronavirus disease 2019 (COVID-19), it has become obvious that it won’t be business as usual when the economy restarts and social distancing restrictions are relaxed," write Steven A. Kaplan, MD, and Alexis E. Te, MD.

April 03, 2020

"Through all this, I have never been more optimistic that together we will be stronger both in the urologic community and the medical community as a whole," writes Steven A. Kaplan, MD.

September 10, 2019

"We have entered a renaissance in the care for patients with benign prostatic hyperplasia-related lower urinary tract symptoms," writes Steven A. Kaplan, MD.

November 14, 2018

"When analyzing efficacy of minimally invasive/surgical therapies for lower urinary tract symptoms secondary to BPH, we appropriately focus on subjective criteria and objective criteria. While we discuss retreatment rates, we don’t measure failure of therapies by how many men restart LUTS/BPH medications," writes Steven A. Kaplan, MD.